Savior Lifetec Corporation (TPEX: 4167)

Market Cap	6.86B
Revenue (ttm)	1.21B
Net Income (ttm)	120.62M
Shares Out	317.40M
EPS (ttm)	0.36
PE Ratio	60.67
Forward PE	n/a
Dividend	0.09 (0.39%)
Ex-Dividend Date	Jul 12, 2024

Volume	901,830
Open	22.20
Previous Close	21.80
Day's Range	21.50 - 22.20
52-Week Range	17.10 - 27.80
Beta	0.59
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 8, 2024

About Savior Lifetec

Savior Lifetec Corporation, a specialty injectable company, develops, produces, and supplies sterile active pharmaceutical ingredients and finished dosage formulations. The company provides various products, such as paliperidone palmitate, cetrorelix and ganirelix acetate, plecanatide, prucalopride succinate, and brinzolamide. It offers imipenem and cilastatin, meropenem, and ertapenem products. Savior Lifetec Corporation was founded in 2004 and is headquartered in Miaoli County, Taiwan.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2004
• Employees: 384
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4167

Financial Performance

In 2023, Savior Lifetec's revenue was 1.05 billion, a decrease of -17.02% compared to the previous year's 1.27 billion. Earnings were 30.03 million, a decrease of -17.47%.